Chief Technical Officer
Mon, Sep 18, 2023
Sep 18
exercised or converted securities in APLS
9,719 shares @ $29.76
Increased holdings by +15.20%
Net across this filing: -14.30% (-10,631 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology